Sentinel lymph node surgery in uncommon clinical circumstances

Surgical Oncology Clinics of North America

Volumn 19, Issue 3, 2010, Pages 539-553

  Ansari, Bijan ^a   Boughey, Judy C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast augmentation; Breast cancer in men; Breast reduction; Internal mammary lymph node; Multifocal breast cancer; Neoadjuvant chemotherapy; Prophylactic mastectomy; Sentinel lymph node

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCURACY; AXILLARY LYMPH NODE; BREAST AUGMENTATION; BREAST BIOPSY; BREAST CANCER; BREAST REDUCTION; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STAGING; CHILDHOOD CANCER; CLINICAL TRIAL; CONGENITAL MALFORMATION; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; MENTAL DEFICIENCY; PATIENT SAFETY; PREGNANT WOMAN; RADIATION DOSE; REVIEW; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE SURGERY; SEX DIFFERENCE; BREAST TUMOR; FEMALE; LYMPH NODE; LYMPHADENECTOMY; PATHOLOGY;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY;

EID: 77954166068     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.03.001     Document Type: Review

References (98)

1. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005, 23(30):7703-7720.
2. Boughey J.C., Bedrosian I., Meric-Bernstam F., et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 2006, 203(4):475-480.
3. Mullan M.H., Kissin M.W. Positive sentinel node biopsy in male breast carcinoma. ANZ J Surg 2001, 71(7):438-440.
4. Hill A.D., Borgen P.I., Cody H.S. Sentinel node biopsy in male breast cancer. Eur J Surg Oncol 1999, 25(4):442-443.
5. Gennari R., Renne G., Travaini L., et al. Sentinel node biopsy in male breast cancer: Future standard treatment?. Eur J Surg 2001, 167(6):461-462.
6. Port E.R., Fey J.V., Cody H.S., et al. Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 2001, 91(2):319-323.
7. Albo D., Ames F.C., Hunt K.K., et al. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 2003, 77(1):9-14.
8. Goyal A., Horgan K., Kissin M., et al. Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol 2004, 30:480-483.
9. De Cicco C., Baio S.M., Veronesi P., et al. Sentinel node biopsy in male breast cancer. Nucl Med Commun 2004, 25(2):139-143.
10. Cimmino V.M., Degnim A.C., Sabel M.S., et al. Efficacy of sentinel lymph node biopsy in male breast cancer. J Surg Oncol 2004, 86(2):74-77.
11. Rusby J.E., Smith B.L., Dominguez F.J., et al. Sentinel lymph node biopsy in men with breast cancer: a report of 31 consecutive procedures and review of the literature. Clin Breast Cancer 2006, 7(5):406-410.
12. Gentilini O., Chagas E., Zurrida S., et al. Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist 2007, 12(5):512-515.
13. Flynn L.W., Park J., Patil S.M., et al. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg 2008, 206(4):616-621.
14. Wisinski K.B., Gradishar W.J. Male breast cancer. Diseases of the breast 2010, 775-780. Lippincott, Williams and Wilkins, Philadelphia. 4th edition. J.R. Harris, M.E. Lippman, M.M. Morrow (Eds.).
15. Pandit-Taskar N., Dauer L.T., Montgomery L., et al. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med 2006, 47(7):1202-1208.
16. Keleher A., Wendt R., Delpassand E., et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 2004, 10(6):492-495.
17. Gentilini O., Cremonesi M., Trifirò G., et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004, 15(9):1348-1351.
18. International Commission on Radiological Protection Publication 84 Available at:, Accessed January 21, 2010. http://icrp.org/docs/ICRP_84_Pregnancy_s.pps.
19. Buscombe J., Paganelli G., Burak Z.E., et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007, 34(12):2154-2159.
20. Chakera A.H., Hesse B., Burak Z., et al. EANM-EORTC recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 2009, 36(10):1713-1742.
21. Alkureishi L.W., Burak Z., Alvarez J.A., et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2009, 16(11):3190-3210.
22. Mondi M.M., Cuenca R.E., Ollila D.W., et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 2007, 14(1):218-221.
23. Khera S.Y., Kiluk J.V., Hasson D.M., et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008, 14(3):250-254.
24. te Velde E.A., Sonke G., Rutgers E.J. Breast cancer and pregnancy: diagnosis and treatment options. Breast Cancer 2009, 12(7):e10.
25. Gentilini O., Cremonesi M., Toesca A., et al. Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging 2010, 37(1):78-83.
26. NCCN practice guidelines 2010. Available at:, Accessed January 25, 2010. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
27. Baxter N.N., Virnig B.A., Durham S.B., et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004, 96(6):443-448.
28. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66.
29. Virnig B.A., Tuttle T.M., Shamliyan T., et al. Ductal carcinoma in situ of the Breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 2010, 102:170-178.
30. Cox C.E., Nguyen K., Gray R.J., et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?. Am Surg 2001, 67(6):513-519.
31. Ansari B., Ogston S.A., Purdie C.A., et al. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg 2008, 95(5):547-554.
32. Dominguez F.J., Golshan M., Black D.M., et al. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Ann Surg Oncol 2008, 15(1):268-273.
33. Morrow M. Axillary surgery in DCIS: is less more?. Ann Surg Oncol 2008, 15(10):2641-2642.
34. Mabry H., Giuliano A.E., Silverstein M.J. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?. Am J Surg 2006, 192(4):455-457.
35. Zavagno G., Carcoforo P., Franchini Z., et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol 2005, 31(7):715-720.
36. Camp R., Feezor R., Kasraeian A., et al. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Breast J 2005, 11(6):394-397.
37. Chao C., Wong S.L., Woo C., et al. Reliable lymphatic drainage to axillary sentinel lymph nodes regardless of tumor location within the breast. Am J Surg 2001, 182(4):307-311.
38. Kim J.H., Heerdt A.S., Cody H.S., et al. Sentinel lymph node drainage in multicentric breast cancers. Breast J 2002, 8(6):356-361.
39. Zavagno G., Rubello D., Franchini Z., et al. Italian Study Group on Radioguided Surgery and ImmunoScintigraphy. Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland. Eur J Surg Oncol 2005, 31(5):479-484.
40. Suami H., Pan W.R., Mann G.B., et al. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol 2008, 15(3):863-871.
41. Schrenk P., Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001, 357(9250):122.
42. Layeeque R., Henry-Tillman R., Korourian S., et al. Subareolar sentinel node biopsy for multiple breast cancers. Am J Surg 2003, 186(6):730-735.
43. Kumar R., Jana S., Heiba S.I., et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med 2003, 44(1):7-10.
44. Gentilini O., Trifirò G., Soteldo J., et al. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Eur J Surg Oncol 2006, 32(5):507-510.
45. Knauer M., Konstantiniuk P., Haid A., et al. Multicentric breast cancer: a new indication for sentinel node biopsy-a multi-institutional validation study. J Clin Oncol 2006, 24(21):3374-3380.
46. D'Eredita' G., Giardina C., Ingravallo G., et al. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer. Breast 2007, 16(3):316-322.
47. Cipolla C., Vieni S., Fricano S., et al. The accuracy of sentinel lymph node biopsy in the treatment of multicentric invasive breast cancer using a subareolar injection of tracer. World J Surg 2008, 32(11):2483-2487.
48. Meretoja T.J., Leidenius M.H., Heikkilä P.S., et al. Sentinel node biopsy in breast cancer patients with large or multifocal tumors. Ann Surg Oncol 2009, 16(5):1148-1155.
49. Fearmonti R.M., Batista L.I., Meric-Bernstam F., et al. False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden. Breast J 2009, 15(6):645-648.
50. Ozmen V., Muslumanoglu M., Cabioglu N., et al. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat 2002, 76(3):237-244.
51. Bergkvist L., Frisell J., Swedish Breast Cancer Group, et al. Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 2005, 92(10):1221-1224.
52. van Deurzen C.H., Vriens B.E., Tjan-Heijnen V.C., et al. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 2009, 45(18):3124-3130.
53. Neuman H.B., Ollila D.W. Sentinel lymph node biopsy controversy: before or after neoadjuvant chemotherapy. Curr Breast Canc Rep 2009, 1(2):71-77.
54. Classe J.M., Bordes V., Campion L., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 2009, 27(5):726-732.
55. Hunt K.K., Yi M., Mittendorf E.A., et al. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 2009, 250:558-566.
56. Schwartz G.F., Tannebaum J.E., Jernigan A.M., et al. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Cancer 2010, 116:1243-1251.
57. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2005, 23(12):2694-2702.
58. Xing Y., Foy M., Cox D.D., et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006, 93(5):539-546.
59. Kelly A.M., Dwamena B., Cronin P., et al. Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis. Acad Radiol 2009, 16(5):551-563.
60. Shen J., Gilcrease M.Z., Babiera G.V., et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 2007, 109(7):1255-1263.
61. Newman E.A., Sabel M.S., Nees A.V., et al. Sentinel lymph node biopsy performed after preoperative chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 2007, 14(10):2946-2952.
62. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007, 8(10):854-855.
63. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998, 339(14):941-946.
64. Gimbergues P., Abrial C., Durando X., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 2008, 15(5):1316-1321.
65. Surgery to remove the sentinel lymph node and axillary lymph nodes after chemotherapy in treating women with stage II, stage IIIA, or stage IIIB breast cancer Available at:, Accessed January 21, 2010. http://clinicaltrials.gov/ct2/show/record/NCT00881361.
66. Haigh P.I., Hansen N.M., Qi K., et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000, 7(1):21-27.
67. Luini A., Galimberti V., Gatti G., et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat 2005, 89(2):159-163.
68. Heuts E.M., van der Ent F.W., Kengen R.A., et al. Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol 2006, 32(3):278-281.
69. Smitt M.C., Horst K. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 2007, 14(3):1040-1044.
70. Jakub J.W., Ebert M.D., Cantor A., et al. Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast Reconstr Surg 2004, 114(7):1737-1742.
71. Gray R.J., Forstner-Barthell A.W., Pockaj B.A., et al. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation. Am J Surg 2004, 188(2):122-125.
72. Rodriguez Fernandez J., Martella S., Trifirò G., et al. Sentinel node biopsy in patients with previous breast aesthetic surgery. Ann Surg Oncol 2009, 16(4):989-992.
73. Munhoz A.M., Aldrighi C., Buschpiegel C., et al. The feasibility of sentinel lymph node detection in patients with previous transaxillary implant breast augmentation: preliminary results. Aesthetic Plast Surg 2005, 29(3):163-168.
74. Sado H.N., Graf R.M., Canan L.W., et al. Sentinel lymph node detection and evidence of axillary lymphatic integrity after transaxillary breast augmentation: a prospective study using lymphoscintigraphy. Aesthetic Plast Surg 2008, 32(6):879-888.
75. Mottura A.A., Del Castillo R. Transaxillary breast augmentation: two breast cancer patients with successful sentinel lymph node diagnosis. Aesthetic Plast Surg 2007, 31(5):544-549.
76. Golshan M., Lesnikoski B.A., Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg 2006, 72(5):397-400.
77. Port E.R., Garcia-Etienne C.A., Park J., et al. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 2007, 14(8):2209-2214.
78. Boughey J.C., Ross M.I., Babiera G.V., et al. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 2006, 7(3):248-253.
79. Intra M., Trifirò G., Galimberti V., et al. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg 2007, 94(10):1216-1219.
80. Boughey J.C., Hunt K.K. Expanding the indications for sentinel lymph node surgery in breast cancer. Future Oncol 2007, 3(1):9-14.
81. Karam A., Stempel M., Cody H.S., et al. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg 2008, 207(4):543-548.
82. Schrenk P., Tausch C., Wayand W. Lymphatic mapping in patients with primary or recurrent breast cancer following previous axillary surgery. Eur J Surg Oncol 2008, 34(8):851-856.
83. Madsen E., Gobardhan P., Bongers V., et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 2007, 14(4):1486-1492.
84. Chen R.C., Lin N.U., Golshan M., et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management-a systematic review. J Clin Oncol 2008, 26(30):4981-4989.
85. Lacour J., Bucalossi P., Cacers E., et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer 1976, 37(1):206-214.
86. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999, 91(4):368-373.
87. van Geel A.N., Wouters M.W., van der Pol C., et al. Chest wall resection for internal mammary lymph node metastases of breast cancer. Breast 2009, 18(2):94-99.
88. Bourre J.C., Payan R., Collomb D., et al. Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?. Eur J Nucl Med Mol Imaging 2009, 36(5):758-764.
89. Noushi F., Spillane A.J., Uren R.F., et al. Internal mammary node metastasis in breast cancer: predictive models to determine status & management algorithms. Eur J Surg Oncol 2010, 36(1):16-22.
90. Zhang YJ, Oh JL, Whitman GJ, et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. Int J Radiat Oncol Biol Phys December 11 2009, [Epub ahead of print].
91. Oh J.L., Buchholz T.A. Internal mammary node radiation: a proposed technique to spare cardiac toxicity. J Clin Oncol 2009, 27(31):e172-e173.
92. Coombs N.J., Boyages J., French J.R., et al. Internal mammary sentinel nodes: ignore, irradiate or operate?. Eur J Cancer 2009, 45(5):789-794.
93. Boughey J.C., Khakpour N., Meric-Bernstam F., et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 2006, 107(7):1440-1447.
94. Laronga C., Lee M.C., McGuire K.P., et al. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg 2009, 209(6):746-752.
95. Boughey J.C., Cormier J.N., Xing Y., et al. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 2007, 110(11):2542-2550.
96. Black D., Specht M., Lee J.M., et al. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol 2007, 14(9):2477-2484.
97. McLaughlin S.A., Stempel M., Morris E.A., et al. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?. Cancer 2008, 112(6):1214-1221.
98. Giuliano A.E., Boolbol S., Degnim A., et al. Society of surgical oncology: position statement on prophylactic mastectomy. Ann Surg Oncol 2007, 14(9):2425-2427.